ENO2 and non-small cell lung carcinoma: Diagnostic indices used clinically for NSCLC include cytokeratin fragment 19 antigen 21-1 (CYFRA21-1), neuron-specific enolase (NSE), and carcinoembryonic antigen (CEA), which, however, were found from relevant studies with modest sensitivity and specificity to meet clinical needs [4].